Werewolf Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Werewolf Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2020 to Q3 2024.
  • Werewolf Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 43.7M shares, a 22.6% increase year-over-year.
  • Werewolf Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 35.6M shares, a 23.5% increase from 2022.
  • Werewolf Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 28.9M shares, a 56.4% increase from 2021.
  • Werewolf Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 18.5M shares, a 1736% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 43.7M +8.05M +22.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 43.5M +7.96M +22.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 41.6M +6.82M +19.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-03
Q4 2023 35.6M +6.78M +23.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 35.7M +5.89M +19.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 35.6M +8.04M +29.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 34.8M +7.39M +27% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 28.9M +10.4M +56.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 29.8M +2.58M +9.48% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 27.5M +9.77M +55% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 27.4M +26.2M +2129% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 18.5M +17.5M +1736% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 27.2M +26.3M +2862% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 17.8M +16.8M +1774% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 1.23M +393K +47% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 1.01M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-24
Q3 2020 918K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 947K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 836K Jan 1, 2020 Mar 31, 2020 10-Q 2021-06-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.